DK0946139T3 - Farmaceutisk formulation - Google Patents

Farmaceutisk formulation

Info

Publication number
DK0946139T3
DK0946139T3 DK97944000T DK97944000T DK0946139T3 DK 0946139 T3 DK0946139 T3 DK 0946139T3 DK 97944000 T DK97944000 T DK 97944000T DK 97944000 T DK97944000 T DK 97944000T DK 0946139 T3 DK0946139 T3 DK 0946139T3
Authority
DK
Denmark
Prior art keywords
methoxypsoralen
pharmacologically
pharmaceutical formulation
optionally
acceptable
Prior art date
Application number
DK97944000T
Other languages
English (en)
Inventor
Robin Morley
Michael Bedford-Stradling
Original Assignee
Crawford Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crawford Healthcare Ltd filed Critical Crawford Healthcare Ltd
Application granted granted Critical
Publication of DK0946139T3 publication Critical patent/DK0946139T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
DK97944000T 1996-10-15 1997-10-14 Farmaceutisk formulation DK0946139T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9621480A GB2318291B (en) 1996-10-15 1996-10-15 8-Methoxypsoralen containing additives for topical application in bath water
PCT/GB1997/002716 WO1998016195A1 (en) 1996-10-15 1997-10-14 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
DK0946139T3 true DK0946139T3 (da) 2002-09-23

Family

ID=10801451

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944000T DK0946139T3 (da) 1996-10-15 1997-10-14 Farmaceutisk formulation

Country Status (9)

Country Link
EP (1) EP0946139B1 (da)
AT (1) ATE218323T1 (da)
AU (1) AU4564797A (da)
DE (1) DE69713143T2 (da)
DK (1) DK0946139T3 (da)
ES (1) ES2178009T3 (da)
GB (1) GB2318291B (da)
WO (1) WO1998016195A1 (da)
ZA (1) ZA979179B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19927168A1 (de) * 1999-06-15 2000-12-21 Cognis Deutschland Gmbh Ölbäder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445422B (sv) * 1979-06-25 1986-06-23 Gerot Pharmazeutika Farmaceutisk beredning for oral administereing innehallande 8-metoxi-furo-/3',2':6,7/-kumarin
CA1173751A (en) * 1980-05-07 1984-09-04 Jack H. Lazarus Methoxsalen dosage forms
US4454152A (en) * 1980-05-07 1984-06-12 Hoffmann-La Roche Inc. Methoxsalen dosage forms
LU85829A1 (fr) * 1985-04-01 1986-11-05 Cird Composition pour bains a base de psoralene dans le traitement du psoriasis
GB9409945D0 (en) * 1994-05-17 1994-07-06 Bioglan Lab Ltd A medicated wipe

Also Published As

Publication number Publication date
DE69713143D1 (de) 2002-07-11
AU4564797A (en) 1998-05-11
GB9621480D0 (en) 1996-12-04
GB2318291B (en) 1998-09-23
GB2318291A (en) 1998-04-22
DE69713143T2 (de) 2003-02-20
WO1998016195A1 (en) 1998-04-23
EP0946139A1 (en) 1999-10-06
ES2178009T3 (es) 2002-12-16
ATE218323T1 (de) 2002-06-15
EP0946139B1 (en) 2002-06-05
ZA979179B (en) 1999-07-14

Similar Documents

Publication Publication Date Title
AU3731997A (en) Emulsion formulations for hydrophilic active agents
PT1052905E (pt) Processo anti-germinativo de tuberculos e bolbos utilizando o eugenol e/ou o isoeugenol
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DE69930964D1 (de) Zusammensetzungen und verfahren für mukosale abgabe
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
ATE123930T1 (de) Darreichungsform für mikrobläschen- echokontrastmittel.
BR9714465A (pt) Composição, utilização de uma associação e utilização de um silicone polioxialquilenado
CO4340621A1 (es) Complejos de inclusion en solucion acuosa de compuestos de benzotiofeno con ciclodextrinas solubles en agua y sus formulaciones farmaceuticas y procedimietos de los mismos
ES2052809T3 (es) Agente desinfectante tuberculocida.
TR199801114T2 (xx) Bir hidrofobik s�v� madde i�eren kararl� em�lsiyon.
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
ES2088965T3 (es) Derivados de rodanina aril-sustituidos.
BR0210493A (pt) Composição, e, método para remover cerume humano
BR9405606A (pt) Uso de amidoaminas em composições oftálmicas
ES2178009T3 (es) Formulacion farmaceutica.
EP1084710A4 (en) DRUGS AGAINST MALE STERILITY
ATE205246T1 (de) Molkerei-reinigungssystemverfahren
DE60034779D1 (de) Insulinartiger-wachstumsfaktorbindungsprotein-4-protease
DE69722525D1 (de) Auslöser für den bluteinsatz
DE3885468D1 (de) Mittel zur verringerung des lipidperoxidgehaltes.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
PT1150716E (pt) Composicao farmaceutica de proteinas hedgehog hidrofobicamente modificadas e sua utilizacao
IT1283324B1 (it) Composizioni veterinarie a base di antibatterici per uso intramammario
ATE306914T1 (de) Wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie